Prospective study to evaluate effect of early treatment of pediatric patients of Influenza A H1N1 (pdm09) with a neuraminidase inhibitor

Trial Profile

Prospective study to evaluate effect of early treatment of pediatric patients of Influenza A H1N1 (pdm09) with a neuraminidase inhibitor

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Dec 2015

At a glance

  • Drugs Oseltamivir (Primary) ; Zanamivir (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Dec 2015 Status changed from not stated to completed.
    • 28 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top